- CSR Summary Not Available
- NCT00236600
- Primary Citation
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment561% Female76%% White98%
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-OBES-004Data PartnerJohnson & JohnsonCondition StudiedObesityMean/Median Age (Years)43.8
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available